Back to Journals » Pharmacogenomics and Personalized Medicine » Breaking Down the Intricacies of Catabolic Enzymes
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (644)
- Volume 17, 2024 (23)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Journal Articles:
Breaking Down the Intricacies of Catabolic Enzymes
Genetic polymorphisms are one way in which people vary from one another. While initial thoughts of "variance" might include a person’s physical features, it is well established that the body’s internal processes are also subject to differ dependent on a multitude of factors. This could include traits that follow them from birth, but also polypharmacy, or even diet. In line with the advances in modern medicine and genetic testing, research has started to explore the plethora of information linked to catabolic enzyme polymorphisms. This can involve specifying polymorphisms of interest, such as the Cytochrome P450 (CYP) family such as those including the location on the chromosome, possible allelic variations and the impact of these polymorphisms on their parent compound, metabolites or other molecules. This Collection explores the role of catabolic enzyme polymorphisms for a wide variety of disease areas, such as oncology, pulmonology, immunology, psychology, cardiology and more.
Maternally Inherited Essential Hypertension May Be Associated with the Mutations in Mitochondrial tRNAGlu Gene
Wang C, Deng X, Li L, Li M
Pharmacogenomics and Personalized Medicine 2024, 17:13-26
Published Date: 9 January 2024
Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
Nguyen TVA, Le BH, Nguyen MT, Le VT, Tran VT, Le DT, Vu DAM, Truong QK, Le TH, Nguyen HTL
Pharmacogenomics and Personalized Medicine 2024, 17:53-64
Published Date: 3 February 2024
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Lv L, Zhang X, Liu Y, Zhu X, Pan R, Huang L
Pharmacogenomics and Personalized Medicine 2024, 17:171-181
Published Date: 22 April 2024
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053
Published Date: 1 December 2023